Street Novelist
Member
- Apr 2, 2018
- 290
- Tinnitus Since
- February 2018
- Cause of Tinnitus
- Listening to loud music through headphones
How do they deliver the drug using this method? Is it still a needle through the eardrum?
How do they deliver the drug using this method? Is it still a needle through the eardrum?
That's good to hear. I had been wondering how Hough Ear Institute was doing with their pill.I'm surprised this thread is as busy as it is with the science being lackluster. I love the idea but I mean let it go guys. This one's not it. They have to go back to the drawing board.
There are others out there fighting for the cure too. Hough Ear Institute told me things are going really well with their proof of concept and are making progress on that front.
Why isn't it possible to hold multiple beliefs?I'm surprised this thread is as busy as it is with the science being lackluster. I love the idea but I mean let it go guys. This one's not it. They have to go back to the drawing board.
There are others out there fighting for the cure too. Hough Ear Institute told me things are going really well with their proof of concept and are making progress on that front.
I never called it a hoax. I'm just wondering why, on multiple threads, people are still talking about FX-322 like it's still the one.Why isn't it possible to hold multiple beliefs?
I can always spot the people who don't do science because they think failure is always an indication that it's all a hoax. Here's an exercise: Go back and listen to the Tinnitus Talk Podcast with Professor Tzounopoulos -- read the transcript if you can't.
He is often dismayed and humbled by the sheer number of failures. He said that at least 90% of his experiments were failures (and honestly, it's probably a lot higher). He will also have many more failures in the future. This is what science is. It's 99% failures, and finally, a breakthrough.
But by saying this, people are going to think that I'm like some loon in denial, too emotionally weak to accept reality. Why can't I believe both? Why can't I say that Phase 2a failed, there's a ton of uncertainty as to why, but also the years of scientific discoveries are not all a hoax? Is that possible?
At least the optimistic people put themselves out there, on display, capable of looking embarrassed. The blind pessimists just give this ignorant, snobbish vibe that's pretty annoying.
If you're going to comment on something negative, say something of substance please.
You're right, you never called it a hoax. I don't want to misrepresent your viewpoints.I never called it a hoax. I'm just wondering why, on multiple threads, people are still talking about FX-322 like it's still the one.
I suffer with this terribly and was really bummed when I got the news, but this thread keeps going and going and I come back like I've missed something. I haven't. It's back to the drawing board.
I see your point a bit on this.I never called it a hoax. I'm just wondering why, on multiple threads, people are still talking about FX-322 like it's still the one.
I suffer with this terribly and was really bummed when I got the news, but this thread keeps going and going and I come back like I've missed something. I haven't. It's back to the drawing board.
You nailed it!!! The whole post!!!You're right, you never called it a hoax. I don't want to misrepresent your viewpoints.
I guess I saw your remarks about "giving it up" as kind of an overreaction. Like yeah, go to the drawing board and be prepared for all of the theories to be wrong. No question, FX-322 could fail outright, but my main point is that there are many aspects of it that are not speculative. It does cure mice, it does work on human cochlea ex vivo, it uses a highly novel PCA approach, it does make it's way into the perilymph (at least in the high frequencies).
There are lots of unknowns as to what's going on in a live human. Does the body prioritize inner hair cells? Does it only work on inner hair cells? Does it hardly work at all in live humans and the 3 super responders from Phase 1/2 were Harvard educated savants that studied the test and aced it the second time?
There is so much to unpack. I understand that the wounds are fresh so people have their guards up. One of the reasons why I've made my timeline 10-20 years is to manage expectations. I do think, though, if I had to bet on one drug to succeed first, it would still be FX-322 just based on probabilities. It's the furthest along and at least has something of interest from Phase 1/2. Who knows though, maybe the delivery is so terrible that this formulation is just a flop? Definitely possible.
I can confidently say this. No offense to HEI, as I'm rooting for them too, but it's a little "grass is greener" to think they have a better chance of succeeding than Frequency Therapeutics. The operative word is "better," not "for sure."
I guess I'm just trying to help people to understand what scientists go through. I'm a research (some present, mostly in the past) mathematician, which is in just one type of science that's far different from lab experiments, but what's kind of funny is if you ever talk to someone who's knee deep in scientific research, they are often like weirdly unconfident. It's because of all of the failures. They fail so often that the humility is not an act to fit in or something. They genuinely feel stupid because their work provides so little short-term reward.You nailed it!!! The whole post!!!
Long unbroken conversations between sufferers about hyped up treatments is part of the day to day coping mechanism.this thread keeps going and going and I come back like I've missed something.
Well, I think the scary part is that they burned their mulligan. What are the three main things we are talking about? Trial design (word score reliability), lawn/perilymph overflow theory, and IHC vs OHC preference. None of these three things were at the forefront of the discussion pre-results. There was definitely more of an interest in the obscene doubling of word scores than the subpar PTA improvements, but the PTA results didn't fall flat on their face like they did in Phase 2a.Even if the severe hearing loss trial shows positive outcomes?
I've just been thinking about the severe hearing loss sufferers, if they don't restore the low frequencies, but restore high-mid frequencies, would that make much difference to a severe hearing loss sufferer? Would that make them hear more high-mid frequencies e.g., birds?Well, I think the scary part is that they burned their mulligan. What are the three main things we are talking about? Trial design (word score reliability), lawn/perilymph overflow theory, and IHC vs OHC preference. None of these three things were at the forefront of the discussion pre-results. There was definitely more of an interest in the obscene doubling of word scores than the subpar PTA improvements, but the PTA results didn't fall flat on their face like they did in Phase 2a.
Something will pop up that's unexpected, and by definition of unexpected, we don't know what it is. I would consider a strong result from the severe trial to be a victory for the future. Even if FX-322 fails, maybe their technology will be built upon. It's a win.
I believe people should be prepared to cope and lean on other things. This story isn't going to end with a miracle drug making our conditions go away. It will be one drug having a breakthrough and improving our lives by 10-20%. Then we are better rested for the next breakthrough that improves it by another 10-20%. Maybe there's a threshold where life is worth it. It never crosses my mind that my life will just go back to normal at some point. I will die with hearing problems, no question.
I guess we'll have to see. The good thing is that strong results presumably mean almost undeniable word score improvements over placebo. I wouldn't know, but I have to imagine if you go from making out 50% of words at a comfortable level in conversation to 80%, that's probably a lot.I've just been thinking about the severe hearing loss sufferers, if they don't restore the low frequencies, but restore high-mid frequencies, would that make much difference to a severe hearing loss sufferer? Would that make them hear more high-mid frequencies e.g., birds?
That's what I'm hoping for. At least if they get good results for the severe hearing loss trial, then we know that FX-322 is the real deal and the other Phase 1b trials weren't a fluke.I guess we'll have to see. The good thing is that strong results presumably mean almost undeniable word score improvements over placebo. I wouldn't know, but I have to imagine if you go from making out 50% of words at a comfortable level in conversation to 80%, that's probably a lot.
There's also an exponential improvement aspect to quality of life. For example, if you miss words here or there, the brain can fill them in. But if you miss 50% of words, it's a much more dramatic difference in understanding the gist of a movie, TV show, conversation, etc. At least, this is what I would think.
Really strong results would also be a good thing because it provides more data than just n=30 more people. It would help them design Phase 2 much better. That's my hope anyways, that a solid severe trial leads to a more straightforward recruiting process for the next Phase 2.
I also don't expect positive Day 210 results.I agree. It's still too early to know how everything works with these new regeneration drugs but I think Frequency Therapeutics are honest people though. I don't think they will lie about a drug that can help with hearing loss and tinnitus. Some of the anecdotes got tinnitus improvements from FX-322.
I'm not expecting the Day 210 to be positive unless somehow many of the patients had experienced more improvements after Day 90 due to weekly dosing of FX-322 killing the process and needing to wait even longer for the regrowing process.
I would be very interested in that information as well. I would have preferred they inject placebo first, then FX-322 as the placebo may be washing out the FX-322.I also don't expect positive Day 210 results.
But for the Day 210 results, I really want to see the individual details.
In addition, if possible, first of all, I would like to see a validation comparing only the single injection group of FX-322 with placebo, except for patients who appear to have cheated.
Then, I would like to see a comparative verification between the single injection group and the multiple injection group.
I have both and men are much easier to hear than women and children. I would much rather have my high frequencies repaired. Too bad FX-322 didn't work.I've just been thinking about the severe hearing loss sufferers, if they don't restore the low frequencies, but restore high-mid frequencies, would that make much difference to a severe hearing loss sufferer? Would that make them hear more high-mid frequencies e.g., birds?
The problem was multiple doses. A single dose would show improvement. FX-322 still works.I'm surprised this thread is as busy as it is with the science being lackluster. I love the idea but I mean let it go guys. This one's not it. They have to go back to the drawing board.
There are others out there fighting for the cure too. Hough Ear Institute told me things are going really well with their proof of concept and are making progress on that front.
Thanks for that information, maybe FX-322 will make a difference for severe hearing loss sufferers.I have both and men are much easier to hear than women and children. I would much rather have my high frequencies repaired. Too bad FX-322 didn't work.
Not too proud to admit I have no clue if this is a reference to Breaking Bad or if you're serious...Our best bet might be an infamous group of scientists developing an IT tinnitus formula. They are rumored to be operating out of a RV someplace in the Nevada desert. Also, buy some FREQ stock as it is very cheap right now.
Also have to take into account that the placebo may have washed FX-322 away as well. Not sure how long FX-322 stays in your ear after injection.The problem was multiple doses. A single dose would show improvement. FX-322 still works.
I think that is a pipe dream. The compound doesn't work, the trial just confirmed that. Back to formula.Thanks for that information, maybe FX-322 will make a difference for severe hearing loss sufferers.
The stock price is a bargain right now. If they can get positive outcomes for both age-related and severe hearing loss sufferers I expect the share price to go back up to $20-$30 and any announcement of the pivotal phase will make it go back up to $60 or more. This is a good time to get back in.I noticed FREQ gained 10% just now. This all feels like just a temporary setback to me.
The reason why it failed is because weekly doses were not effective. If you take a look at previous trials, they have stated single dosing of FX-322 was more effective.I think that is a pipe dream. The compound doesn't work, the trial just confirmed that. Back to formula.
To be fair, we don't know if the next results will be positive. I believe in FX-322 but I think we need to lower our expectations.The reason why it failed is because weekly doses were not effective. If you take a look at previous trials, they have stated single dosing of FX-322 was more effective.
There will be people here still saying FX-322 won't work when the positive outcomes for age-related and severe hearing loss trials come out in June and Q3.
Good point, but if I see positive outcomes for the severe hearing loss trial, I'll be back on team bull.To be fair, we don't know if the next results will be positive. I believe in FX-322 but I think we need to lower our expectations.
The company still has trials that are active; so select few don't yet see the dead-end for FX-322. It's not exactly normal to see a single drug applied this many parallels at once, let alone a hearing drug, especially two Phase 1s for a similar underlying condition (SNHL) after a Phase 2 flopped for basically, SNHL.Everyone's very defensive. I understand why.
Honestly I'm not trying to belittle the science, the achievement, etc. Of course, as one of "us" I was rooting big time for them. But my opinion is, if the mechanism worked, we'd see more positive results, or statistically significant changes. You have to understand what this company had riding on these results. Tons of money. If there was a twinkle in the eye it would've been reported. They had to swallow their pride and admit nothing was gained right now.
And for the record - gains made in mice doesn't mean much. They're good for testing mechanisms and hypotheses, and indications of whether or not to move forward - but we are different. Curing mice doesn't guarantee anything at all for us. Unfortunately.
On the bright side, progress. Failure is progress. And, Frequency Therapeutics are not the only players in the game.
COVID-19 causing tinnitus is a small silver lining.